dessin d'un cerveau

PSP TPE Project 2024-2026

Therapeutic Education programme

This project aims to create the first national therapeutic education programme for progressive supranuclear palsy (PSP) patients.

PSP is a rare neurodegenerative disease that progressively affects mobility and causes with problems with balance, swallowing, speech and vision. This programme is an opportunity to maintain patients’ and carers’ quality of life.

Progressive supranuclear palsy (PSP) is a rare and complex neurodegenerative disease characterised by motor, cognitive and behavioural disorders. At Angers University Hospital, the Memory Research and Resource Centre is a centre of expertise for rare forms of dementia, including PSP. There is currently no national therapeutic education (TPE) programme for this disease. However, its progression requires patients and their carers to develop coping skills. The development of a TPE programme provides a crucial opportunity for patients and their carers to maintain or even improve their quality of life with this incurable disease.

This programme sets out to meet a number of essential needs :

  • Patient autonomy – PSP leads to a progressive loss of autonomy. This programme will help patients develop a better understanding of their disease, recognise the symptoms and make decisions about their daily lives. Adapting their daily activities could slow their loss of autonomy and help them maintain the best possible quality of life.
  • Support for carers – care givers play a crucial role in the treatment of patients. The programme will include a workshop dedicated to carers, which will provide them with tools and strategies for managing the disease on a daily basis and dealing with difficult behaviour. This will help to reduce carer burnout and improve the overall care environment.
  • Multidisciplinary management – the complexity of PSP requires a multidisciplinary approach. Based on this principle, the programme will involve 14 PSP specialists from 10 different professions to ensure comprehensive and coherent treatment.
  • Improved understanding of the care pathway – by actively involving patients in their care pathway, TPE addresses the progression of the disease and presents possible strategies for providing optimal support. A palliative care doctor who has been trained in TPE will also participate in the programme.

This programme, featuring seven group workshops, will be developed in partnership with the PSP France association. It will be proposed at various stages of the disease, but particularly at the time of diagnosis and when swallowing problems appear.

Download the program

ETP - PSP France program (pdf, 471.42 kB)